glp-1 drugs moa Discovery of GLP-1–Based for the Treatment of Obesity Mechanisms of action of GLP-1RA.

doi:10.1016/j.biomaterials.2015.01.074 157

In mice with high fat diet (HFD)-induced obesity, JBSNF-000088 caused a reduction in body weight, improved insulin sensitivity and normalized glucose tolerance to the level of lean control mice

This relatively small GPCR family is characterized by a long extracellular ligand-binding domain stabilized by three disulfide bridges formed by six highly conserved cysteine residues, seven -helical transmembrane domains, universal for all GPCRs and an intracellular C-terminal domain, responsible mostly for receptor internalization due to the presence of multiple phosphorylation sites [22, 23]

Human Pluripotent Stem Cell Culture: Current Status, Challenges, and Advancement